Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Outlook Therapeutics, Inc. (OTLK) click here.